Freeze-Dried Platelet Product for the Treatment of Trauma-Associated Blood Loss in Canines
| Agency: | DEPT OF DEFENSE |
|---|---|
| State: | Maryland |
| Type of Government: | Federal |
| FSC Category: |
|
| NAICS Category: |
|
| Set Aside: | No Set aside used |
| Posted Date: | Feb 1, 2026 |
| Due Date: | Mar 2, 2026 |
| Solicitation No: | HT9427-26-RFI-703 |
| Original Source: | Please Login to View Page |
| Contact information: | Please Login to View Page |
| Bid Documents: | Please Login to View Page |
Description
APEX Accelerators are an official government contracting resource for small businesses. Find your local APEX Accelerator (opens in new window) for free government expertise related to contract opportunities.
APEX Accelerators are funded in part through a cooperative agreement with the Department of Defense.
The APEX Accelerators program was formerly known as the Procurement Technical Assistance Program (opens in new window) (PTAP).
- Contract Opportunity Type: Sources Sought (Original)
- Original Published Date: Jan 30, 2026 12:23 pm EST
- Original Response Date: Mar 02, 2026 02:00 pm EST
- Inactive Policy: 15 days after response date
- Original Inactive Date: Mar 17, 2026
-
Initiative:
- None
- Original Set Aside: No Set aside used
- Product Service Code:
- NAICS Code:
-
Place of Performance:
MD 21702USA
The OPMED is conducting market research to identify technologies that meet requirements for the development of a freeze-dried platelet product for the treatment of trauma-associated blood loss in canines. This market research may also assist with the further development and/or refinement of the requirements.
Military Working Dogs (MWDs) play a critical role in protecting human lives and supporting military objectives in the operational environment. MWDs work in close conjunction with their handlers and Service Members and are exposed to the same combat trauma threats and similar non-battle injury risks, and thus canine blood or blood components are indicated for appropriate treatment.
The OPMED has a requirement to develop, deliver, and field safe and effective Canine Blood Products (CBP) for the treatment of traumatic hemorrhage. The CBP program is using a Family of Systems (FoS) approach that aims to develop multiple medical materiel solutions that are most relevant for use in austere environments where medical products and evacuation may be limited.
This RFI seeks responses to the canine freeze-dried platelet component of this FoS only.
North American Industry Classification System (NAICS) Code: Unknown.
RFI Attachments: The following documents are attached to the RFI: A02-RFI for Freeze Dried Platelet Canine
Attachment 1: Technology Readiness Levels (TRLs) (Reference Only)
Attachment 2: Company & Product Information
Response Due Date: Interested parties shall submit the RFI response electronically by 2:00pm Eastern on March 2, 2026, via e-mail to:
Katherine Ramsburg via email at: katherine.j.ramsburgciv@health.mil
Email Subject/title: "RFI response for HT9427-26-RF
- MEDICAL R & D CONTRACTING DIVISION 2 808 SCHREIDER STREET
- FORT DETRICK , MD 21702
- USA
- Katherine Ramsburg
- katherine.j.ramsburg.civ@health.mil
- Julie Burns
- julia.l.burns3.civ@health.mil
- Jan 30, 2026 12:23 pm ESTSources Sought (Original)
See Also
Follow BPA - X-RAY FILM AND SUPPLIES PSC 6525 Active Contract Opportunity Notice
DEPT OF DEFENSE
Due by 11/11/2028
Follow BPA - X-RAY FILM AND SUPPLIES PSC 6525 Active Contract Opportunity Notice
DEPT OF DEFENSE
Due by 11/11/2028
Follow BPA - X-RAY FILM AND SUPPLIES PSC 6525 Active Contract Opportunity Notice
DEPT OF DEFENSE
Due by 11/11/2028
Follow Notice of Intent to Sole Source - Miltenyi Biotec, Inc Active Contract
HEALTH AND HUMAN SERVICES, DEPARTMENT OF